Skip to search formSkip to main contentSkip to account menu

KMT5C gene

Known as: lysine methyltransferase 5C, MGC2705, SUPPRESSOR OF VARIEGATION 4-20, DROSOPHILA, HOMOLOG OF, 2 
This gene is involved in epigenetic control of gene expression.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Breast cancer is the most common type of cancer in women worldwide. Triple methylation of H4 lysine 20 (H4K20me3), a key… 
2017
2017
Chromosomal alterations are commonly detected in patients with chronic lymphocytic leukemia (CLL) and impact disease pathogenesis… 
2015
2015
.....................................................................................................................................3 INTRODUCTION:..........................................................................................................................4 EPIGENETICS IN CANCER......................................................................................................5 GENE EXPRESSION PROFILING IN CANCER.........................................................................7 GENE EXPRESSION PROFILING IN PEDIATRIC EPENDYMOMA.........................................8 WHAT IS PEDIATRIC EPENDYMOMA?.........................................................................................9 ALTERED CHROMATIN STATES IN CANCER.......................................................................12 ALTERED CHROMATIN STATES IN PEDIATRIC EPENDYMOMA.......................................13 HISTONE MODIFYING ENZYME SUV4-20H2 EFFECT ON CHROMATIN STATE...................13 METHODS:....................................................................................................................................16 ANALYSIS OF MICROARRAY DATA......................................................................................16 REAL-TIME PCR FOR VALIDATION OF MICROARRAY DATA...............................................18 ANALYSIS OF REAL-TIME PCR DATA...................................................................................19 CHROMATIN IMMUNOPRECIPITATION.............................................................................20 REAL-TIME PCR OF CHIP PULLDOWNS (AND ANALYSIS)..................................................23 ChIP-SEQUENCING..............................................................................................................23 RESULTS:......................................................................................................................................26 THERE ARE SIGNIFICANTLY ALTERED PATTERNS OF GENE EXPRESSION IN SUBTYPES OF PEDIATRIC EPENDYMOMA..........................................................................26 POOR PROGNOSIS SUBGROUP SHOWS ALTERED EXPRESSION OF GENES RELATED TO CELL CYCLE REGULATION, TUMOR SUPPRESSION, AND DNA REPLICATION AND REPAIR.................................................................................................27 MICROARRAY ALTERED EXPRESSION VALIDATED AND REPLICATED IN VCU COHORT OF PEDIATRIC EPENDYMOMA.............................................................................29 SUV4-20H2 BINDS NEAR TERT PROMOTER........................................................................31 H4K20me2 AND H4K20me3 MODIFICATION ARE FOUND NEAR TERT PROMOTER..........................................................................................................................33 ChIP-SEQUENCING EXPERIMENTS.....................................................................................34 DISCUSSION:...............................................................................................................................36 REFERENCES:.............................................................................................................................41 TABLES:........................................................................................................................................45 Table 1: ChIP-qPCR RESULTS WITH anti-SUV4-20H2 ......................................................................58 Table 2: ChIP-qPCR RESULTS WITH anti-H4K20me2 ......................................................................61 Table 3: ChIP-qPCR RESULTS WITH anti-H4K20me3 ......................................................................62 FIGURES:......................................................................................................................................45 Figure 1: EPIGENETIC MODIFICATIONS AND CHROMATIN STATE ................................................45